10x Genomics, Inc. (TXG) — 10-Q Filings

10-Q Filings (6)

• 10x Genomics Narrows Losses, Boosts Cash on Settlement Gain — Nov 7, 2025 Risk: medium
  10x Genomics, Inc. (TXG) reported a net loss of $27.472 million for the three months ended September 30, 2025, an improvement from the $35.753 million net loss
• 10x Genomics Q2 Revenue Jumps 15% to $150M — Aug 8, 2025 Risk: medium
  10x Genomics, Inc. reported total revenue of $150.0 million for the second quarter of 2025, a significant increase from $130.0 million in the second quarter of
• 10x Genomics Q1 2025 10-Q Filed — May 9, 2025 Risk: medium
  10x Genomics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance, including product and service revenue and lice
• 10x Genomics Files Q3 2024 10-Q — Oct 29, 2024 Risk: medium
  10x Genomics, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quart
• 10x Genomics Q2 2024 10-Q Filing — Aug 8, 2024 Risk: medium
  10x Genomics, Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter and the first half of the fiscal year. Key financial
• 10x Genomics, Inc. Files 10-Q for Period Ending March 31, 2024 — Apr 30, 2024 Risk: low
  10x Genomics, Inc. (TXG) filed a Quarterly Report (10-Q) with the SEC on April 30, 2024. 10x Genomics, Inc. filed a 10-Q report for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX